Table 1 Patients main characteristics
Variable | RT n = 68 | CRT n = 72 | P |
|---|---|---|---|
Age (years) | 65.6 (SD = 9.5) | 63.14 (SD = 10.1) | 0.141 |
Gender (%) | |||
Male | 43 (63.2) | 50 (69.4) | 0.437 |
Female | 25 (36.8) | 22 (30.6) | |
ASA1 (%) | 1 (1.5) | 1 (1.4) | |
ASA2 (%) | 32 (48.5) | 31 (43.1) | 0.808 |
ASA3 (%) | 33 (50) | 40 (55.5) | |
Period from the end of | |||
neoadjuvant therapy till surgery (days) | 48.03 (SD = 12.5) | 47.14 (SD = 8.6) | 0.622 |
Clinical stage (%) | |||
II | 16 (23.5) | 15 (20.8) | 0.701 |
III | 52 (76.5) | 57 (79.2) | |
Tumor distance from anal | |||
verge (%) | |||
< 5 cm | 34 (50) | 30 (41.7) | |
5–10 cm | 29 (42.6) | 37 (51.4) | 0.575 |
11–15 cm | 5 (7.4) | 5 (6.9) | |